Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
glucose
59%
plasma
55%
levels
49%
risks
42%
metabolism
40%
insulin
37%
data
37%
diseases
35%
inflammation
35%
genes
35%
populations
30%
atherosclerosis
26%
cardiovascular diseases
25%
complement
25%
genetics
24%
methylation
23%
intake
23%
liver
22%
dna
22%
obesity
22%
diabetes mellitus
21%
blood
21%
lipids
20%
sex
20%
humans
19%
comparative evaluations
18%
biological markers
18%
fats
17%
concentration
17%
proteins
17%
Keyphrases
Maastricht Study
100%
Type 2 Diabetes Mellitus (T2DM)
49%
CODAM
25%
Pre-diabetes (pre-DM)
22%
Diabetes
21%
Insulin Resistance
16%
Low-grade Inflammation
16%
Cardiovascular Disease
14%
Endothelial Dysfunction
12%
Methylglyoxal
12%
Normal Glucose Metabolism
11%
Obesity
10%
Advanced Glycation End Products
9%
Glucose Metabolism Status
9%
DNA Methylation (DNAm)
8%
Habitual Intake
8%
Neurodegeneration
8%
Dicarbonyls
8%
Metabolic Syndrome
7%
Arterial Stiffness
7%
Non-associated
7%
Cardiovascular Risk Factors
7%
Familial Combined Hyperlipidemia
7%
Inflammation
7%
3-deoxyglucosone
6%
Physical Activity
6%
Maastricht
6%
Hepatic Fat
6%
Expression Quantitative Trait Loci (eQTL)
6%
Glucose Metabolism
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
39%
Diabetes
23%
Glucose Metabolism
20%
Inflammation
19%
Impaired Glucose Tolerance
18%
Cardiovascular Disease
15%
Biological Marker
12%
Glucose
12%
Atherosclerosis
12%
Insulin Resistance
11%
Endothelial Dysfunction
11%
Advanced Glycation End-Product
9%
Methylglyoxal
7%
Diseases
7%
Oral Glucose Tolerance Test
7%
Arterial Stiffness
7%
Fatty Liver
7%
Body Mass Index
6%
Neurodegeneration
6%
Metabolic Syndrome
6%
Blood Pressure
6%
Adipose Tissue
6%
Cohort Analysis
5%
Familial Hyperlipidemia
5%
Complement Activation
5%
Cardiovascular System
5%
Complement Component C3
5%